Sinopharm Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 1

Professionals
  • Investments
  • 71

  • Portfolio
  • 50

  • Exits
  • 8

Exits

Sinopharm Capital General Information

Description

Sinopharm Capital is a venture capital arm of Sinopharm Group focusing on medical and health fields. The firm is primarily based in Shanghai, China and prefers to invest in the healthcare, life science and biotechnology sectors.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Number 266, Hankou Road
  • 16th Floor
  • Shanghai, Huangpu 200010
  • China

Sinopharm Capital Investments (71)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
AstraBio (China) 29-Jun-2022 Early Stage VC 000.00 Biotechnology Startup
00000000 000000000 31-Mar-2022 00000 00000 000.00 Drug Discovery Startup 000 0000
000000000 0000000 31-Mar-2022 0000 00000 00.000 Enterprise Systems (Healthcare) Startup 00000 00
000000000 03-Mar-2022 00000 00000 000.00 Drug Discovery Generating Revenue
0000000000 14-Feb-2022 00000 00000 000.00 Biotechnology Pre-Clinical Trials
00000000 (0000000 24-Nov-2021 00000 00000 Laboratory Services (Healthcare) Clinical Trials - General
00000 000000000000 15-Nov-2021 00000 00000 000.00 Biotechnology Generating Revenue
000000000 02-Nov-2021 00000 00000 000.00 Diagnostic Equipment Generating Revenue
Neowise Biotechnology 14-Oct-2021 Early Stage VC Drug Discovery Startup
Xiyuan Anjian Pharmaceutical 01-Oct-2021 Seed Round 000.00 Drug Discovery Startup
You’re viewing 10 of 71 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sinopharm Capital Exits (8)

Company Name Exit Date Exit Type Exit Size
Abbisko Therapeutics 13-Oct-2021 IPO 00000
00000 18-Jun-2021 000 00000
0000 06-May-2021 000 000.00
000000 000000 0000 04-Dec-2020 000 00 00000000
000000000 29-Jul-2020 000 00000
00000 000000000000 10-Oct-2019 000000000000000000 00000
Guangzhou Ambition (LBP) Pharmaceutical Technology 23-Dec-2016 Merger/Acquisition 00000
Oramed Pharmaceuticals Secondary Transaction - Open Market
To view Sinopharm Capital’s complete exits history, request access »

Sinopharm Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Sinopharm Capital Team (3)

Name Title Deals Funds Boards Office
Aimin Wu Founder, Managing Partner & President 0 0 Shanghai, China
Han Zhao Executive 0 Shanghai, China
Xiaoming Yang Executive Shanghai, China
To view Sinopharm Capital’s complete team members history, request access »

Sinopharm Capital Co-Investors (114)

Name With Exits Lead Partner Series Industry
CICC Capital 4 Series chart Industry bar
China Growth Capital 0 0 Series chart Industry bar
Lilly Asia Ventures 0 0 0 Series chart Industry bar
Qiming Venture Partners 0 0 Series chart Industry bar
TF Capital 0 Series chart Industry bar
You’re viewing 5 of 114 co-investors. Get the full list »